Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial - Dummer, R; Ascierto, PA; Gogas, Helen (Lancet Oncol, 2018)